Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous neurogenesis refers to the process by which new neurons are generated from endogenous neural stem or progenitor cells within the adult brain, primarily in two regions: the subventricular zone (SVZ) and the subgranular zone (SGZ) of the hippocampus[1][2][3][5]. These stem or progenitor cells can proliferate, migrate, and differentiate into neurons and glial cells, contributing to neural plasticity, memory, and brain repair. Modulating endogenous neurogenesis is a major area of research for regenerative medicine in neurodegenerative diseases and brain injury, but it is not a discrete molecular drug target[1][3][5].
Enhancement of proliferation, differentiation, or survival of neural stem/progenitor cells; Modulation of signaling pathways involved in neurogenesis (e.g., serotonin signaling, BDNF-TrkB signaling, Wnt, Shh)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous neurogenesis.